scholarly journals Combinatorial analyses reveal that cellular composition changes have different impact on transcriptomic changes of cell type specific genes in Alzheimer’s Disease brains

2020 ◽  
Author(s):  
Shunian Xiang ◽  
Travis Johnson ◽  
Tianhan Dong ◽  
Zhi Huang ◽  
Michael Cheng ◽  
...  

Abstract Background Alzheimer’s disease (AD) brains are characterized by progressive neuron loss and gliosis which involves mostly microglia and astrocytes. Comparative transcriptomic analysis on AD vs. normal brain tissues helps to identify key genes/pathways involved in AD initiation and progression. However, many such studies using bulk brain tissue samples have not considered cell composition changes in AD brains, which may lead to expression changes that are not due to transcriptional regulation. Methods Using five large transcriptomic datasets including 1,681 brain tissue samples (882 AD, 799 normal) in total, we first mined frequent co-expression network modules across them, then combined differential expression and differential co-expression analysis on the mined modules in AD versus normal brains. Integrated with cell type deconvolution analysis, we addressed the question of whether the module expression changes are due to altered cellular composition or transcriptional regulation. We then used four additional large AD/normal transcriptomic datasets to validate our findings. Results The integrative analysis revealed highly elevated expression level of microglia modules in AD without co-expression change. Decreased expression and elevated co-expression are observed for neuron modules in AD, while significant over-expression and co-expression perturbation are observed in astrocyte modules, all of which has not been previously reported. The expression levels of astrocyte modules also show the strongest correlation with the clinicopathological biomarkers among all cell type specific modules. Conclusion Further analysis indicated that the overall increased expression of the core microglia modules can be well explained by the increased microglia cell population in AD brains instead of bona fide microglia genes’ upregulation. In contrast, the decreased expression and perturbed co-expression in AD neuron modules are due to both neuron cell loss and expression regulation of neuronal pathways including differentially expressed transcription factors such as BCL6 and STAT3, which previous study was not able to identify from the shadow of the cellular composition change. Similarly, the strong changes in expression and co-expression in the astrocyte modules may be also due to a combinatory effect from astrogliosis and astrocyte gene activation in AD brains. In this work, we demonstrated that the combinatorial analyses not only provide a powerful approach to delineate the origin of transcriptomic changes in bulk tissue data, but also lead to a deeper understanding of genes in AD.

2020 ◽  
Author(s):  
Travis S. Johnson ◽  
Shunian Xiang ◽  
Tianhan Dong ◽  
Zhi Huang ◽  
Michael Cheng ◽  
...  

Abstract Alzheimer’s disease (AD) brains are characterized by progressive neuron loss and gliosis. Previous studies comparing AD versus control using bulk brain tissue samples have not considered cell composition changes in AD brains that can cause transcriptional changes not due to transcriptional regulation.Using five large transcriptomic datasets, we mined conserved gene co-expression network modules, and applied differential expression and differential co-expression analysis on the modules in AD versus control brains. Combined with cell type deconvolution analysis, we addressed the question of whether the module expression changes are due to altered cellular composition or transcriptional regulation. Our findings were validated using four additional datasets.We discovered that the increased expression of microglia modules can be explained by increased microglia population in AD brains rather than gene upregulation. In contrast, the decreased expression and perturbed co-expression in AD neuron modules are due to both neuron loss and regulation of neuronal pathways and several transcriptional factors are identified for such regulation. Similarly, the strong changes in expression and co-expression in astrocyte modules can also be attributed to a combinatory effect from astrogliosis and astrocyte gene activation in AD brains. The astrocyte modules expressions also strongly correlated with the clinicopathological biomarkers.In summary, we demonstrated that combinatorial analysis is a powerful approach to delineate the origin of transcriptomic changes in bulk tissue data, which leads to a deeper understanding of key genes/pathways in AD.


2020 ◽  
Author(s):  
Travis S. Johnson ◽  
Shunian Xiang ◽  
Tianhan Dong ◽  
Zhi Huang ◽  
Michael Cheng ◽  
...  

Abstract Alzheimer’s disease (AD) brains are characterized by progressive neuron loss and gliosis. Previous studies comparing AD versus control using bulk brain tissue samples have not considered cell composition changes in AD brains that can cause transcriptional changes not due to transcriptional regulation.Using five large transcriptomic datasets, we mined conserved gene co-expression network modules, and applied differential expression and differential co-expression analysis on the modules in AD versus control brains. Combined with cell type deconvolution analysis, we addressed the question of whether the module expression changes are due to altered cellular composition or transcriptional regulation. Our findings were validated using four additional datasets.We discovered that the increased expression of microglia modules can be explained by increased microglia population in AD brains rather than gene upregulation. In contrast, the decreased expression and perturbed co-expression in AD neuron modules are due to both neuron loss and regulation of neuronal pathways and several transcriptional factors are identified for such regulation. Similarly, the strong changes in expression and co-expression in astrocyte modules can also be attributed to a combinatory effect from astrogliosis and astrocyte gene activation in AD brains. The astrocyte modules expressions also strongly correlated with the clinicopathological biomarkers.In summary, we demonstrated that combinatorial analysis is a powerful approach to delineate the origin of transcriptomic changes in bulk tissue data, which leads to a deeper understanding of key genes/pathways in AD.


2019 ◽  
Vol 13 ◽  
Author(s):  
Corinna Höfling ◽  
Emira Shehabi ◽  
Peer-Hendrik Kuhn ◽  
Stefan F. Lichtenthaler ◽  
Maike Hartlage-Rübsamen ◽  
...  

2020 ◽  
Vol 117 (41) ◽  
pp. 25800-25809 ◽  
Author(s):  
Shun-Fat Lau ◽  
Han Cao ◽  
Amy K. Y. Fu ◽  
Nancy Y. Ip

Alzheimer’s disease (AD) is the most common form of dementia but has no effective treatment. A comprehensive investigation of cell type-specific responses and cellular heterogeneity in AD is required to provide precise molecular and cellular targets for therapeutic development. Accordingly, we perform single-nucleus transcriptome analysis of 169,496 nuclei from the prefrontal cortical samples of AD patients and normal control (NC) subjects. Differential analysis shows that the cell type-specific transcriptomic changes in AD are associated with the disruption of biological processes including angiogenesis, immune activation, synaptic signaling, and myelination. Subcluster analysis reveals that compared to NC brains, AD brains contain fewer neuroprotective astrocytes and oligodendrocytes. Importantly, our findings show that a subpopulation of angiogenic endothelial cells is induced in the brain in patients with AD. These angiogenic endothelial cells exhibit increased expression of angiogenic growth factors and their receptors (i.e.,EGFL7,FLT1, andVWF) and antigen-presentation machinery (i.e.,B2MandHLA-E). This suggests that these endothelial cells contribute to angiogenesis and immune response in AD pathogenesis. Thus, our comprehensive molecular profiling of brain samples from patients with AD reveals previously unknown molecular changes as well as cellular targets that potentially underlie the functional dysregulation of endothelial cells, astrocytes, and oligodendrocytes in AD, providing important insights for therapeutic development.


2007 ◽  
Vol 179 (8) ◽  
pp. 5493-5503 ◽  
Author(s):  
Amir Afkhami-Goli ◽  
Farshid Noorbakhsh ◽  
Avril J. Keller ◽  
Nathalie Vergnolle ◽  
David Westaway ◽  
...  

1986 ◽  
Vol 20 (2) ◽  
pp. 265-267 ◽  
Author(s):  
Julian N. Kanfer ◽  
Hiroshi Hattori ◽  
Danka Orihel

2018 ◽  
Author(s):  
Saranya Canchi ◽  
Balaji Raao ◽  
Deborah Masliah ◽  
Sara Brin Rosenthal ◽  
Roman Sasik ◽  
...  

AbstractWhile Alzheimer’s disease (AD) is the most prevalent cause of dementia, complex combinations of the underlying pathologies have led to evolved concepts in clinical and neuropathological criteria in the past decade. Pathological AD can be decomposed into subsets of individuals with significantly different antemortem cognitive decline rates. Using transcriptome as a proxy for functional state, we preselected 414 expression profiles of clinically and neuropathologically confirmed AD subjects and age matched non-demented controls sampled from a large community based neuropathological study. By combining brain tissue specific protein interactome with gene network, we identify functionally distinct composite clusters of genes which reveal extensive changes in expression levels in AD. The average global expression for clusters corresponding to synaptic transmission, metabolism, cell cycle, survival and immune response were downregulated while the upregulated cluster had a large set of uncharacterized pathways and processes that may constitute an AD specific phenotypic signature. We identified four master regulators across all clusters of differentially expressed genes by enrichment analysis includingTGIF1andEGR3.These transcription factors have previously not been associated with AD and were validated in brain tissue samples from an independent AD cohort. We identifyTGIF1,a transcriptional repressor as being neuroprotective in AD by activating co-repressors regulating genes critical for DNA repair, maintaining homeostasis and arresting cell cycle. In addition, we show that loss ofEGR3regulation, mediates synaptic deficits by targeting the synaptic vesicle cycle. Collectively, our results highlight the utility of integrating protein interactions with gene perturbations to generate a comprehensive framework for characterizing the alterations in molecular network as applied to AD.


2020 ◽  
Vol 16 (S3) ◽  
Author(s):  
Ornit Chiba‐Falek ◽  
Julio Barrera ◽  
Lingyun Song ◽  
Alexias Safi ◽  
Young Jun Yu ◽  
...  

2019 ◽  
Vol 15 ◽  
pp. P1496-P1496
Author(s):  
Kevin Green ◽  
Elizabeth Blue ◽  
Benjamin A. Logsdon ◽  
Brad Rolf ◽  
Shannon Rose ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document